ADVERTISEMENT

Over 1 in 4 patients with a cardiac implantable electronic device experiences subclinical atrial fibrillation

Jenny Blair, MD   |   Clinical Summary   |   20 July 2022
ADVERTISEMENT

Takeaway

  • More than 28% of patients with cardiac implantable electronic devices (CIEDs) experience subclinical atrial fibrillation (SCAF) and resultant higher risk for several bad outcomes.
  • Authors call for more research into the use of oral anticoagulants in these patients.

Why this matters

  • SCAF refers to atrial high-rate episodes (AHREs) in patients...

          

January Challenge

Ends in 2d 14h
left
right

Topic Challenges

left
right